Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $425,508 | $522,435 | $571,062 | $1,881,743 |
| - Cash | $249,645 | $106,276 | $116,312 | $193,227 |
| + Debt | $402,265 | $249,068 | $247,974 | $204,611 |
| Enterprise Value | $578,128 | $665,227 | $702,724 | $1,893,127 |
| Revenue | $306,584 | $295,938 | $276,236 | $241,926 |
| % Growth | 3.6% | 7.1% | 14.2% | – |
| Gross Profit | $140,779 | $131,833 | $133,187 | $117,572 |
| % Margin | 45.9% | 44.5% | 48.2% | 48.6% |
| EBITDA | -$10,652 | -$68,281 | -$82,916 | -$101,682 |
| % Margin | -3.5% | -23.1% | -30% | -42% |
| Net Income | -$69,502 | -$118,147 | -$137,403 | -$153,210 |
| % Margin | -22.7% | -39.9% | -49.7% | -63.3% |
| EPS Diluted | -1.15 | -2.09 | -2.54 | -3.23 |
| % Growth | 45% | 17.7% | 21.4% | – |
| Operating Cash Flow | $14,559 | -$33,080 | -$35,270 | -$23,123 |
| Capital Expenditures | -$16,398 | -$14,311 | -$17,414 | -$18,467 |
| Free Cash Flow | -$1,839 | -$47,391 | -$52,684 | -$41,590 |